News - Ani Bookmark

microfluidics based point-of-care diagnostics

Bellasmith121 Dec, 2022News

Point-of-care technology (POCT) diagnostic systems are tools that can rapidly lead to in vitro diagnostic (IVD) results by non-trained personnel at a patient site in varieties of locations such as the field, the home, the ambulance, or the hospital. To this day, diagnostic tests are typically operated at laboratories equipped with bench-top analyzers and managed by trained personnel. That is to say, there have been a few days to wait before patients receive their testing results.

microfluidic protein detection

Bellasmith121 Dec, 2022News

As a leading service provider in the field of microfluidic systems, Creative Biolabs has launched an integrated platform for the development of a wide range of rapid and sensitive microfluidic chips to achieve protein digestion, identification, and analysis using electrospray ionization mass spectrometry (ESI-MS) or many other mass spectrometry (MS) detections.

Next Generation Probiotics Services for Autism Spectrum Disorder (ASD)

Bellasmith121 Dec, 2022News

With the growing research on probiotics and the integral part, they play in the health of the gastric intestinal (GI) tract and the whole body, their inclusions as an integrative treatment may be of great use for children with ASD. Creative Biolabs provides a series of next-generation probiotics (NGPs) discovery and analysis services characterized by quality, predictability, delivery, and customization. Our employees have the operational courage and scientific background that you need for your success.

Football Transfer News, Live Updates: Chelsea approach Man United's Garnacho

Sportsliveresults21 Dec, 2022News

Premier League giants have showed their interest in Manchester United wonderkid Garnacho and Juventus midfielder Weston McKennie. Reportedly, Barcelona forward Memphis Depay, defenders Hector Bellerin, Franck Kessie, Jordi Alba and captain Sergio Busquets are likely to move to a new club in January. While Depay,

cga antibody

Bellasmith121 Dec, 2022News

Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients’ requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results.

PD-L1 Antibody Optimization

Bellasmith121 Dec, 2022News

Creative Biolabs provides a full range of immune checkpoint antibody development services from antibody discovery to preclinical trials in a timely and cost-effective manner. Our featured services include monoclonal antibody development, phage display antibody library construction and screening, antibody humanization, antibody production, bispecific antibody development, and so on. Besides, we also support immune checkpoint small molecule drug development and immune checkpoint assays to meet your specific requirement. Moreover, we also provide a series of high-quality immune checkpoint-related products to support your immune checkpoint research and drug discovery projects.

KCTD2 pU6 shRNA

Bellasmith121 Dec, 2022News

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA).

Production of Glycan Antibody by Phage Display

Bellasmith121 Dec, 2022News

During the past years, Creative Biolabs has successfully established an advanced phage display platform as well as Hyperdoma™ platform for specific antibody production. Based on these mature technologies, now we are capable of providing first-class customized anti-glycan antibody development services for research, diagnostic, as well as therapeutic antibody developments.

hook1 antibody

Bellasmith121 Dec, 2022News

Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies. Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.

Belimumab Biobetter

Bellasmith121 Dec, 2022News

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.